受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、虚增利润黑洞触发强制退市 医药行业昔日的明星企业普利制药，终究未能逃脱法律的制裁。2025年3月21日，中国证监会下发《行 政处罚决定书》，彻底击碎了公司长期维持的业绩幻象。 经监管部门调查核实，普利制药在2021年至2022年期间，通过有组织的手段进行大规模财务造假，其造 假金额之大、手段之恶劣，令市场哗然。 （本文由上海沪紫律师事务所刘鹏律师供稿，不代表新浪财经的观点。刘鹏律师，专注证券维权19年， 自2006年执业以来，成功为中青宝、国华网安、劲嘉股份（维权）等 300 余家上市公司的中小投资者成 功维权，案件在办数量超过 14000 起，胜诉率达 99.2%。作为业内资深证券维权律师，刘鹏律师精准把 握案件核心，诉讼经验丰富，索赔策略高效，为投资者争取最大权益，维权实力行业领先。证券维权， 选对律师是关键！专业决定胜算，经验确保结果，首选刘鹏律师，让您的索赔更稳妥、更高效！）（刘 鹏律师专 ...

责任编辑：韦子蓉 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 2026年1月8日，上海久诚律师事务所股票索赔许峰收到法院送达的普利制药（300630）上诉状，普利制 药对投资者胜诉提起上诉。前期许峰律师代理的普利制药投资者索赔案收到海口市中级人民法院一审判 决，投资者获得一审胜诉。律师团队同步还在继续推进后续案件的立案工作，还在继续接受其他投资者 的索赔委托。（许峰律师专栏） 2025年3月21日，普利制药公告公司于2025年1月4日收到证监会下发的《行政处罚决定书》。经查明， 2021年至2022年，普利制药通过虚构成品药和原料药销售业务的方式，虚假确认药品销售收入和利润。 其中，2021年多计营业收入436，606，838.34元，占当年披露营业收入的28.94%，对应营业成本128， 588，402.85元，多计利润总额308，018，435.49元，占当年披露利润总额的65.88%；2022年多计营业 收入456，639，341.72元 ...

Group 1 - Hainan Airlines (600221) focuses on international, domestic, and regional air passenger and cargo transportation, operating nearly 1800 routes and covering all provinces in China, as well as over 100 international routes [1][30] - Hainan Airport (600515) operates major airports in Hainan and is involved in airport construction, management, and related industries, including aircraft maintenance and logistics [2][31] - Zhongtung High-tech (000657) is a state-owned enterprise focusing on the tungsten and hard alloy industry, with a complete industrial chain from tungsten ore to products, and is involved in high-end manufacturing sectors [3][32] Group 2 - Jinpan Technology (688676) is a key player in the new energy sector, specializing in the research and manufacturing of power distribution and control equipment, benefiting from supportive policies in Hainan [4][33] - Haixia Co., Ltd. (002320) controls important maritime transport routes, enhancing its passenger and cargo transport services, and is positioned to benefit from increased demand post-border closure [5][34] - Hainan Mining (601969) focuses on mineral resource extraction and processing, with products supporting the new energy battery industry, and is exploring green development models [6][35] Group 3 - Hainan Rubber (601118) is a leading enterprise in natural rubber production, extending its business into rubber products and international trade, leveraging Hainan's free trade policies [7][36] - Guangsheng Nonferrous (600259) specializes in non-ferrous metal mining and smelting, with a focus on rare earths and tungsten, essential for high-end manufacturing and new energy sectors [8][37] - Haima Automobile (000572) is transitioning into the new energy vehicle sector, supported by Hainan's policies, and is expanding its production capabilities [9][38] Group 4 - Haide Co., Ltd. (000567) focuses on distressed asset management, with a strategy to optimize asset allocation in the region, and is involved in photovoltaic projects [10][39] - Hainan Public Transport Group (603069) provides passenger transport services and is enhancing its operations through the integration of duty-free services [11][40] - Junda Co., Ltd. (002865) is engaged in the new energy sector, focusing on photovoltaic battery research and manufacturing, and is expanding its market presence [12][41] Group 5 - Luoniushan (000735) is involved in livestock farming and related industries, leveraging Hainan's agricultural resources to expand its market [13][42] - Jingliang Holdings (000505) focuses on oil processing and food manufacturing, utilizing Hainan's logistics advantages for trade [14][43] - Hainan Coconut Island (600238) specializes in alcoholic beverages, particularly health wines, and is expanding its market through tourism channels [15][44] Group 6 - Hainan Haiyao (000566) is a pharmaceutical manufacturer focusing on chemical raw materials and traditional Chinese medicine, benefiting from supportive policies for the pharmaceutical industry [16][45] - Hainan Ruize (002596) produces construction materials and is involved in tourism, aligning its business with Hainan's infrastructure development [17][46] - Hainan Expressway (000886) operates key highways in Hainan and is expanding its business through tourism and duty-free services [18][47] Group 7 - Puli Pharmaceutical (300630) specializes in chemical drug development and international market expansion, leveraging Hainan's trade policies [19][48] - Shennong Technology (300189) focuses on seed research and production, aiming to expand its market through trade policies [20][49] - Shuangcheng Pharmaceutical (002693) is dedicated to peptide drug development and international market expansion, supported by Hainan's policies [21][50] Group 8 - Xinlong Holdings (000955) specializes in non-woven fabrics and related products, with a focus on medical and industrial applications, and is exploring export opportunities [22][51] - ST Intercontinental (600759) is involved in oil and gas exploration and is expanding into the hydrogen energy sector [23][52] - Huawen Group (000793) operates in media, tourism, and supply chain services, aiming for growth through Hainan's logistics advantages [24][53]

登录新浪财经APP 搜索【信披】查看更多考评等级 2025年12月23日，上海久诚律师事务所股票索赔律师许峰代理的普利制药（300630）投资者索赔案收到 海口市中级人民法院一审判决，投资者获得一审胜诉。律师团队同步还在继续推进后续案件的立案工 作，还在继续接受其他投资者的索赔委托。（许峰律师专栏） 2025年3月21日，普利制药公告公司于2025年1月4日收到证监会下发的《行政处罚决定书》。经查明， 普利制药2021年多计营业收入514，604，184.72元，占当年披露营业收入的34.11%，对应营业成本 206，585，749.23元，多计利润总额308，018，435.49元，占当年披露利润总额的65.88%；2022年多计 营业收入515，899，077.56元，占当年披露营业收入的28.56%，对应营业成本128，481，820.04元，多 计利润总额387，417，257.52元，占当年披露利润总额的88.27%。普利制药披露的2021年年报、2022年 年报存在虚假记载。 投资者索赔律师许峰认为，根据收到的投资者胜诉判决，在2022年4月26日到2024年4月17日之间买入普 利制药股票，并且 ...

2025年3月21日，普利制药公告公司于2025年1月4日收到证监会下发的《行政处罚决定书》。经查明， 普利制药2021年多计营业收入514，604，184.72元，占当年披露营业收入的34.11%，对应营业成本 206，585，749.23元，多计利润总额308，018，435.49元，占当年披露利润总额的65.88%；2022年多计 营业收入515，899，077.56元，占当年披露营业收入的28.56%，对应营业成本128，481，820.04元，多 计利润总额387，417，257.52元，占当年披露利润总额的88.27%。普利制药披露的2021年年报、2022年 年报存在虚假记载。 投资者索赔律师许峰认为，根据收到的投资者胜诉判决，在2022年4月26日到2024年4月17日之间买 入普利制药股票，并且在2024年4月17日后卖出或继续持有股票的投资者，目前还可发起索赔。（普利 制药维权入口） 除了普利制药投资者索赔获得胜诉，2025年12月23日，许峰律师代理的海南华铁（维权）（603300）投 资者索赔案继续向杭州市中级人民法院提交立案，此前已多次提交立案，目前正在等待法院的下一步安 排，律师团 ...

二、财报造假被严惩 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、投资者获一审胜诉 一份证监会的行政处罚决定书，揭开了普利制药两年虚增利润超6.69亿元的财务黑洞，而如今海口市中 级人民法院的一审判决，让那些因虚假报告蒙受损失的投资者看到了索赔的希望。 根据最新消息，海口市中级人民法院已对投资者诉普利制药证券虚假陈述责任纠纷案件作出一审胜诉判 决，公司需赔付股民损失。如公司上诉将进入二审。（刘鹏律师专栏） 回溯此案，2025年3月21日，公司收到证监会的处罚决定，因财务造假极其严重触及重大违法强制退 市，该公司已在4月正式告别A股。 投资者于2022年4月26日-2024年4月16日期间买入，并在2024年4月17日之后卖出或仍持有而亏损的 即可报名索赔。（普利制药维权入口） 据公告，证监会认定公司通过虚构成品药和原料药销售业务、开展贸易业务按总额法核算的方式，虚增 收入和利润。经计算，公司2021年、2022年虚假记载的营业收入金额合计 ...

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 根据最高人民法院虚假陈述司法解释，上市公司等因证券虚假陈述行为导致投资者权益受损，投资者可 以依法起诉索赔，索赔范围包括投资差额损失、佣金和印花税损失。 "上市公司退市，不影响投资者索赔资格。"厉健律师表示，根据司法解释，暂定：在2022年4月26日到 2024年4月16日期间买入普利制药股票，并且在2024年4月16日收盘还持有该股票的的受损股民，可索 赔。索赔条件以法院认定为准。 投资者索赔需提供证券开户信息查询单、股票对账单（2022年4月1日至今）、联系方式等。 【本文由浙江裕丰律师事务所厉健律师供稿，不代表新浪财经的立场。厉健律师，系中国法学会证券法 学研究会理事、中国证券业协会证券纠纷调解员，2009年荣获"浙江省优秀青年律师"称号。2003年至 今，厉健律师代理投资者告赢五粮液、大智慧等130余家上市公司并获赔，成效显著。其中，祥源文 化、赵薇案入选2019年度人民法院十大商事案例， ...

综上，普利制药2021年多计营业收入514，604，184.72元，占当年披露营业收入的34.11%，对应营业成 本206，585，749.23元，多计利润总额308，018，435.49元，占当年披露利润总额的65.88%；2022年多 计营业收入515，899，077.56元，占当年披露营业收入的28.56%，对应营业成本128，481，820.04元， 多计利润总额387，417，257.52元，占当年披露利润总额的88.27%。普利制药披露的2021年年报、2022 年年报存在虚假记载。 专门从事投资者索赔法律事务的上海久诚律师事务所主任许峰律师认为，在2022年4月26日到2024年4月 17日之间买入普利制药股票，并且在2024年4月17日后卖出或继续持有股票的投资者，目前还可发起索 赔。（普利制药维权入口） （本文由上海久诚律师事务所主任许峰律师供稿，不代表新浪财经立场。许峰律师，2008年起律师执 业，执业服务范围涉及虚假陈述、内幕交易、操纵市场等证券欺诈领域索赔代理。十几年来已代理近两 百只股票的投资者胜诉或调解获赔，同期还在代理诉讼时效内近三百只股票的索赔案件，部分也已有胜 诉以及调解获赔 ...

Core Viewpoint - The establishment of the Hainan Free Trade Port and its full closure starting December 18 will create significant opportunities for various industries, particularly in manufacturing and new materials, by implementing favorable tax policies such as "zero tariffs" for certain imported goods [2][3]. Group 1: Hainan Free Trade Port Overview - The full closure of Hainan Island will create a special customs supervision area, allowing for a series of liberalized policies that facilitate trade with foreign countries while managing imports from the mainland [2]. - The "zero tariff" policy will apply to certain goods imported into Hainan, significantly reducing costs for manufacturing enterprises that require large amounts of equipment and raw materials [2][3]. Group 2: Tax Policies and Economic Impact - The processing value-added exemption from import duties applies to goods produced by encouraged industries that either do not contain imported materials or have over 30% value added from processing in Hainan [3]. - The total value of goods sold domestically under the processing value-added exemption has exceeded 10 billion yuan, with over 800 million yuan in import duties exempted, enhancing the competitiveness of Hainan's manufacturing sector [3]. Group 3: Expansion of Zero Tariff Goods - The range of goods eligible for the "zero tariff" policy has expanded significantly from over 1,900 items to more than 6,600 items, increasing the proportion of zero-tariff goods from 21% to 74% of all tariff items [3]. Group 4: Benefiting Industries - The petrochemical new materials industry in Hainan is highlighted as a key beneficiary, with a historical high output value projected for 2024 and consistent double-digit growth over the past four years [4]. - The Hainan government is promoting a complete industrial chain from upstream exploration and development to downstream new materials production, focusing on olefins, aromatics, and natural gas [4]. Group 5: Key Enterprises in Hainan - The top enterprises in Hainan's manufacturing sector for 2024 include China Petroleum & Chemical Corporation (Sinopec) Hainan Refining & Chemical Co., with a projected revenue of 7.89 billion yuan, followed by Hainan Natural Rubber Industry Group Co. and Hainan Yisheng Petrochemical Co. [6][7].

Group 1 - Multiple listed companies received notices from regulatory authorities regarding suspected violations of information disclosure laws [1][4][7] - Haide Co. is under investigation by the CSRC for suspected information disclosure violations, with its actual controller Wang Guangxi being investigated [1] - Tianfeng Securities also received a notice from the CSRC for suspected information disclosure violations and illegal financing [4] Group 2 - Yuanda Intelligent received a pre-penalty notice from the Liaoning Securities Regulatory Bureau for falsely reporting sales revenue in multiple annual reports [7] - Puli Pharmaceutical, which has been delisted, received a pre-penalty notice for failing to disclose its 2024 annual report on time [10] - ST Shenhua was fined 7 million yuan for false records in its annual reports from 2018 to 2021, with the company correcting its financial data [13][14]